Approvals/TGA/ACAMPROSATE-WGR acamprosate calcium 333 mg enteric coated tablets blister

Approved

STANDARD

ACAMPROSATE-WGR acamprosate calcium 333 mg enteric coated tablets blister

GM Pharma International Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 48e927acc72f2d6b
Product Name: ACAMPROSATE-WGR acamprosate calcium 333 mg enteric coated tablets blister
Artg Id: 286653
Artg Name: ACAMPROSATE-WGR acamprosate calcium 333 mg enteric coated tablets blister
Sponsor: GM Pharma International Pty Ltd
Company Detail Path: /organization/gm-pharma-international-pty-ltd
Artg Date: 2017-12-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/fd3e3e5082930b0fd47a570bd3652bbe.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/fea465808c9621738c25912160a6daa4.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

48e927acc72f2d6b

Type

Standard